Journal Logo

Articles by Hunter B. Moore, MD

Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?

Moore, Hunter B.; Moore, Ernest E.; Chapman, Michael P.; More

Journal of the American College of Surgeons. 229(1):92-101, July 2019.

Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy?

Moore, Hunter B.; Paniccia, Alessandro; Lawson, Peter J.; More

Journal of the American College of Surgeons. 227(1):55-62, July 2018.

Viscoelastic Tissue Plasminogen Activator Challenge Predicts Massive Transfusion in 15 Minutes

Moore, Hunter B.; Moore, Ernest E.; Chapman, Michael P.; More

Journal of the American College of Surgeons. 225(1):138-147, July 2017.

Plasma Is the Physiologic Buffer of Tissue Plasminogen Activator-Mediated Fibrinolysis: Rationale for Plasma-First Resuscitation after Life-Threatening Hemorrhage

Moore, Hunter B.; Moore, Ernest E.; Gonzalez, Eduardo; More

Journal of the American College of Surgeons. 220(5):872-879, May 2015.

Massive Plasminogen Activator Inhibitor-1 (PAI-1) Upregulation and Suppressed Fibrinolysis Is the Predominant Phenotype in Severely Injured Trauma Patients

Chapman, Michael P.; Moore, Ernest E.; Moore, Hunter B.; More

Journal of the American College of Surgeons. 219(3):S46, September 2014.

Show: